Goin Kathleen, Chief Operating Officer of Palvella Therapeutics, Inc. ($PVLA), sold about $1.55 million in company shares through seven open market transactions over the last year. Her most recent sale occurred on February 18, 2026. These sales rank her 3,992nd among 11,678 insiders in our database by total value sold, below the average of $8.59 million across roughly six transactions per insider. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 18, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | M | Stock Option (Right to Buy) | 2148 | $0.00 | 15,036.0000 | 11,836,490 | 12.50% | 0.02% |
| March 18, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | M | Common Stock | 2154 | $7.14 | 2,154.0000 | 11,836,490 | 9999.99% | 0.02% |
| March 18, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | M | Common Stock | 2148 | $9.08 | 4,302.0000 | 11,836,490 | 99.72% | 0.02% |
| March 18, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | S | Common Stock | 2268 | $117.56 | 2,034.0000 | 11,836,490 | 52.72% | 0.02% |
| March 18, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | S | Common Stock | 1730 | $118.37 | 304.0000 | 11,836,490 | 85.05% | 0.01% |
| March 18, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | S | Common Stock | 304 | $119.08 | 0.0000 | 11,836,490 | 100.00% | 0.00% |
| March 18, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | M | Stock Option (Right to Buy) | 2154 | $0.00 | 15,089.0000 | 11,836,490 | 12.49% | 0.02% |
| Feb. 18, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | M | Stock Option (Right to Buy) | 2148 | $0.00 | 17,184.0000 | 11,836,490 | 11.11% | 0.02% |
| Feb. 18, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | M | Common Stock | 2154 | $7.14 | 2,154.0000 | 11,836,490 | 9999.99% | 0.02% |
| Feb. 18, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | M | Common Stock | 2148 | $9.08 | 4,302.0000 | 11,836,490 | 99.72% | 0.02% |
| Feb. 18, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | S | Common Stock | 3026 | $79.16 | 1,276.0000 | 11,836,490 | 70.34% | 0.03% |
| Feb. 18, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | S | Common Stock | 1276 | $79.97 | 0.0000 | 11,836,490 | 100.00% | 0.01% |
| Feb. 18, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | M | Stock Option (Right to Buy) | 2154 | $0.00 | 17,243.0000 | 11,836,490 | 11.10% | 0.02% |
| Feb. 5, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | A | Stock Option (Right to Buy) | 48956 | $0.00 | 48,956.0000 | 11,836,490 | 9999.99% | 0.41% |
| Jan. 21, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | M | Stock Option (Right to Buy) | 2148 | $0.00 | 19,332.0000 | 11,836,490 | 10.00% | 0.02% |
| Jan. 21, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | M | Common Stock | 2154 | $7.14 | 2,154.0000 | 11,836,490 | 9999.99% | 0.02% |
| Jan. 21, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | M | Common Stock | 2148 | $9.08 | 4,302.0000 | 11,836,490 | 99.72% | 0.02% |
| Jan. 21, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | S | Common Stock | 553 | $95.49 | 3,749.0000 | 11,836,490 | 12.85% | 0.00% |
| Jan. 21, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | S | Common Stock | 3749 | $97.94 | 0.0000 | 11,836,490 | 100.00% | 0.03% |
| Jan. 21, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | M | Stock Option (Right to Buy) | 2154 | $0.00 | 19,397.0000 | 11,836,490 | 9.99% | 0.02% |
| Dec. 17, 2025 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | M | Common Stock | 2148 | $9.08 | 4,302.0000 | 11,836,490 | 99.72% | 0.02% |
| Dec. 17, 2025 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | S | Common Stock | 4302 | $96.47 | 0.0000 | 11,836,490 | 100.00% | 0.04% |
| Dec. 17, 2025 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | M | Stock Option (Right to Buy) | 2154 | $0.00 | 21,551.0000 | 11,836,490 | 9.09% | 0.02% |
| Dec. 17, 2025 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | M | Stock Option (Right to Buy) | 2148 | $0.00 | 21,480.0000 | 11,836,490 | 9.09% | 0.02% |
| Dec. 17, 2025 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | M | Common Stock | 2154 | $7.14 | 2,154.0000 | 11,836,490 | 9999.99% | 0.02% |
| Nov. 19, 2025 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | M | Stock Option (Right to Buy) | 2154 | $0.00 | 23,705.0000 | 11,836,490 | 8.33% | 0.02% |
| Nov. 19, 2025 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | M | Common Stock | 2154 | $7.14 | 2,154.0000 | 11,836,490 | 9999.99% | 0.02% |
| Nov. 19, 2025 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | M | Common Stock | 2148 | $9.08 | 4,302.0000 | 11,836,490 | 99.72% | 0.02% |
| Nov. 19, 2025 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | S | Common Stock | 1500 | $85.72 | 2,802.0000 | 11,836,490 | 34.87% | 0.01% |
| Nov. 19, 2025 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | S | Common Stock | 2802 | $86.51 | 0.0000 | 11,836,490 | 100.00% | 0.02% |
| Nov. 19, 2025 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | M | Stock Option (Right to Buy) | 2148 | $0.00 | 23,628.0000 | 11,836,490 | 8.33% | 0.02% |
| Feb. 5, 2025 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | A | Non-Qualified Stock Option (right to buy) | 123559 | $0.00 | 123,559.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2025 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | A | Incentive Stock Option (right to buy) | 5373 | $0.00 | 5,373.0000 | 0 | 9999.99% | 0.00% |
| Dec. 13, 2024 | PALVELLA THERAPEUTICS, INC. | $PVLA | Goin Kathleen | Chief Operating Officer | A | Stock Option (right to buy) | 27843 | $0.00 | 27,843.0000 | 0 | 9999.99% | 0.00% |